PLoS ONE (Jan 2021)

TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease.

  • Christian B Lindstad,
  • Alisa E Dewan,
  • Jorunn Stamnaes,
  • Ludvig M Sollid,
  • M Fleur du Pré

DOI
https://doi.org/10.1371/journal.pone.0259082
Journal volume & issue
Vol. 16, no. 11
p. e0259082

Abstract

Read online

A hallmark of celiac disease is the gluten-dependent production of antibodies specific for deamidated gluten peptides (DGP) and the enzyme transglutaminase 2 (TG2). Both types of antibodies are believed to result from B cells receiving help from gluten-specific CD4+ T cells and differentiating into antibody-producing plasma cells. We have here studied the collaboration between DGP- and TG2-specific B cells with gluten-specific CD4+ T cells using transgenic mice expressing celiac patient-derived T-cell and B-cell receptors, as well as between B-cell transfectants and patient-derived gluten-specific T-cell clones. We show that multivalent TG2-gluten complexes are efficient antigens for both TG2-specific and DGP-specific B cells and allow both types of B cells to receive help from gluten-specific T cells of many different specificities.